Boston Healthcare Associates en Data Information Intelligence werken samen aan vermarkting van data uit levenswetenschappen
BOSTON & BERLIJN & LEIPZIG, Duitsland–(BUSINESS WIRE)– Boston Healthcare Associates, Inc. (Boston Healthcare), een internationaal consultancybureau voor de levenswetenschappen, en Data Information Intelligence GmbH (dii) hebben vandaag een nieuwe samenwerking aangekondigd. De twee bedrijven vermarkten samen data en data-analyses uit de levenswetenschappen ten bate van biofarmaceuten, fabrikanten van medische apparatuur en diagnostiekbedrijven.
Boston Healthcare en dii ontwikkelen een gezamenlijk productaanbod voor cliënten die toegang willen tot data en analyse-instrumenten in Europa, het Midden-Oosten en Zuid- en Noord-Amerika. Het aanbod bestaat uit gegevens van meer dan zevenduizend ziekenhuizen en laboratoria, met een focus op gedetailleerde kennis over installaties in meer dan 2400 ziekenhuizen en labs, en klinisch-diagnostische testvolumes, trends, systemen en reactanten die in gebruik zijn voor moleculaire en in-vitrotests in meer dan 1500 labs.
Boston Healthcare Associates and Data Information Intelligence Announce Global Life Sciences Data Commercialization Partnership |
|||||
|
BOSTON & BERLIN & LEIPZIG, Germany–(BUSINESS WIRE)– Boston Healthcare Associates, Inc. (Boston Healthcare), a global life sciences consultancy, and Data Information Intelligence GmbH (dii) today announced a new partnership to develop and commercialize life sciences data and analytics for biopharmaceutical, medical device, and diagnostic companies. Boston Healthcare and dii will provide a joint offering for clients who need access to data and analytics across Europe, the Middle East, and the Americas. The offering includes access to data from over 7,000 hospitals and labs, with a focus on detailed insights on installations from over 2,400 hospitals and labs, and clinical diagnostics testing volumes, trends, systems, and reagents used for Molecular and IVD tests in over 1,500 labs. “We are excited to announce this new agreement with dii, which will not only expand our global market analytics offering, but more importantly will deliver highly granular insight into how diagnostic tools are adopted by treating clinicians and laboratories globally,” said Joseph Ferrara, president of Boston Healthcare. Clinical diagnostics are increasing in importance and value as the development and demand for targeted, precision medicines grow. The partnership between Boston Healthcare and dii will provide biopharmaceutical, medical device, and diagnostic companies with unparalleled access to detailed datasets and customizable reports regarding the global market for diagnostic tests. “Our research institute aggregates and analyzes a unique and centralized dataset that provides a comprehensive understanding of key country-specific life science market dynamics and clinical practice approaches”, said Kathrin Franke, managing director of dii. “This level of analysis leads to deep comparative insights across key global markets.” To learn more about Boston Healthcare’s partnership with dii, as well as the company’s strategic consulting services to biopharmaceutical, medical device, and diagnostics clients worldwide, visit www.bostonhealthcare.com. About Boston Healthcare Associates, Inc. With offices in Boston, Berlin, and Shanghai, our unique approach, combining strategic consulting with a broad understanding of the evidence-driven value environment, gives clients a real-world edge in assessing and capturing global market and business development opportunities. About Data Information Intelligence GmbH (dii) View source version on businesswire.com: http://www.businesswire.com/news/home/20170531005142/en/ Contacts Boston Healthcare Associates, Inc. |
|||||